In cognitively healthy older adults, APOE4 can accelerate their age‐related memory decline with APOE4 carriers earlier than ten years than non‐carriers in Aβ‐positive elderly [131] and progress earlier to MCI or AD [132]. This evidence concerns the gene APOE and Alzheimer disease.